Research Advances in Liposomes for Antitumor Therapy

As a classic nanocarrier delivery system, liposomes significantly enhance drug stability and bioavailability. By prolonging in vivo circulation time and improving tumor-targeting capability, they exhibit unique advantages and considerable value in cancer treatment. This review outlines the basic composition and common preparation methods of liposomes, and systematically introduces their classifications and respective characteristics. It highlights recent advances in liposome applications for treating breast cancer, lung cancer, and glioma, discusses key challenges in clinical translation, and offers perspectives on improving therapeutic efficacy and safety through optimized preparation processes, novel materials, and innovative drug delivery strategies.